All UK companies at BIO-Europe

UK companies attending BIO-Europe 2012 as part of the official delegation

(Click here to search profiles):

Exhibitors
BioPartner.co.uk, UK stand, booth #73
Almac Group, booth #70
Datatrial, booth #72
cddi Ltd, booth #27

UK stand
Advocates Pharmaceutical & Healthcare, Almac Discovery, AMRI, Aptuit, Arecor, BIA(UK BioIndustry Association), Cambridge Bioscience, Crescendo Biologics, CrystecPharma, Diamond BioPharma, Epistem, Galen, Glythera, Haemostatix, ICT Biosciences, Molecular Profiles, Nova Language Services, Pathology Diagnostics,  Penn Pharmaceutical Services, Phynova, Physiomics, Proimmune, Q-Chip, Sareum, SCM Pharma, Selcia, Sera Laboratories, Vivacta

UK companies associated with the delegation*:
Astex Pharmaceuticals, Atebion BDS, Biopta, Coulter Partners, CXR Biosicences, Domainex,  Entrepreneurs Fund, Halo Bioconsulting, Hypha Discovery, Illetrop, Kymab, MasterControl Global, Mercury Pharma, Novozymes Biopharma, Pharmawave, Present Value, Redx Pharma, Sygnature Discovery, Warner Chilcott 

Scottish Delegation:
Scottish Development International (SDI), booth #87
Aptuit (Glasgow), Antoxis, Biopta, Brainwave Discovery, CXR Biosciences, Cyclacel Pharmaceuticals, Health Technologies at Strathclyde University, Hologic Gen-Probe, Illetrop, MGB Biopharma, Nexus Oncology, QCTR, Scottish Biomedical, Sistemic, Symbiosis Pharmaceutical Services, TPP Global Development

All attending UK companies:
3M Health Care Limited, A4P Bio, Abingworth, Acacia Pharma, Adaptimmune, Advocates Pharmaceutical & Healthcare, Almac Discovery, Almac Group, Almac Sciences, Antitope, Antoxis, aPODD Foundation, Aptiv Solutions, Aptuit (Glasgow), Aptuit (Sterile Fill Finish), Aquapharm Biodiscovery, Arecor, Ark Therapeutics, Astellas Pharma Europe, Astex Pharmaceuticals Inc, AstraZeneca, Atebion BDS,  Avillion, Baxter BioPharma Solutions, BIA (UK BioIndustry Association), Bio2Business, Biocatalysts, BioOutsource, BioPartner.co.uk, BioPharm Insight, Biopharma Technology, Biopta, Biosell, Biotec Services International, Bird & Bird LLP, Brainwave Discovery, Cambridge Bioscience, Cancer Research Technology, Cancer Research UK, Catalent MRT, Catalent Pharma Solutions, cddi, Charles River, Clinigen, Cmed Clinical Services, Cobra Biologics, College Hill Life Sciences, Coulter Partners, Crescendo Biologics, CrystecPharma, Current Partnering, CXR Biosciences, Cyclacel Pharmaceuticals, Datatrial, Diamond Pharma Services Limited, Domainex, Eisai, Eli Lilly and Company, Emergent BioSolution, Entrepreneurs Fund Management LLP, Epistem, ERA Consulting (UK), Ergomed, Esperante, Essen BioScience, EUSA Pharma, EvaluatePharma, Fasken Martineau LLP, Ferghana Partners, Forresters, Fujifilm Diosynth Biotechnologies, Fusion Antibodies, Galen, Gerson Lehrman Group, Gill Jennings & Every LLP, GlaxoSmithKline, GlobalData, Glythera, Group H, GW PHARMACEUTICALS, Haemostatix, Halo BioConsulting, Harlan Laboratories, Health Technologies at Strathclyde University, Heptares Therapeutics, Hologic Gen-Probe , Horizon Discovery, Hospira One 2 One, Hypha Discovery, ICT Biosciences, Illetrop, Imanova Limited, Immune Targeting Systems (ITS), Immunocore, IMS Health, Innovaro Pharmalicensing, InVentiv Health Europe, Ipsen Group, Kilburn & Strode LLP, Kymab Limited, LA-SER Europe, LA-SER Europe, MasterControl Global, Medius Associates, Medtrack, Mercury Pharma, Merrill DataSite, Mewburn Ellis LLP, MGB Biopharma, Molecular Profiles, Mundipharma International, MVM Life Sciences, Nature Publishing Group, NDA Group, Newcastle University, Nexus Oncology, Norgine, Nova Language Services UK, NovaSecta, Novella Clinical, Novozymes Biopharma UK, One Nucleus, Ono Pharma UK, Oxford BioMedica Plc, Oxford BioTherapeutics, Patients Direct, Paul Capital, Peakdale Molecular, Penn Pharmaceutical Services, PharmaVentures, Pharmawave, Phynova Group, Physiomics plc, Phytopharm plc, PolyTherics, PRECOS, Present Value, PRMA Consulting, ProImmune, Q-Chip, QCTR, R&D Focus Drug News, Redx Pharma, RUSSLAN Clinical Research, Saccharides Science & Technology, Sage Healthcare, Sareum, Saturn Biosciences, SCM Pharma, Scottish Biomedical, Scottish Development International, Sekisui Enzymes, Selcia, Sera Laboratories International, SGS Vitrology, Shield Therapeutics, Sinclair IS pharma, Sistemic, Summit Corporation plc, Sygnature Discovery, Symbiosis Pharmaceutical Services Limited, Syncona Partners, Syntaxin, Talentmark, The Institute of Cancer Research, Theradex Europe, Thiologics, Thomson Reuters, TPP Global Development Limited, University of Dundee, University of Nottingham, Vectura, Vernalis, Virttu Biologics, Vivacta Limited, Warner Chilcott, Warwick Ventures, Xention

*BioPartnership Programme members are hyperlinked